亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam

医学 肺结核 左氧氟沙星 利福平 内科学 安慰剂 不利影响 人口 结核菌素 结核分枝杆菌 置信区间 外科 抗生素 病理 微生物学 替代医学 环境卫生 生物
作者
Greg James Fox,Nguyen Viet Nhung,Nguyen Cam Binh,Nguyen Binh Hoa,Frances L. Garden,Andrea Benedetti,Pham Ngoc Yen,Nguyen Kim Cuong,Emily Lai-Ho MacLean,H. Manisha Yapa,David W. Dowdy,Nguyễn Hữu Lân,Elyse Guevara-Rattray,Pham Duc Cuong,Ori Solomon,Marcel A. Behr,Ben J. Marais,Steven M. Graham,Dick Menzies,Thu Anh Nguyen
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
卷期号:391 (24): 2304-2314 被引量:70
标识
DOI:10.1056/nejmoa2314325
摘要

BACKGROUND: infection among contacts of persons with drug-resistant tuberculosis are lacking. METHODS: infection. The trial population comprised household contacts of persons with bacteriologically confirmed rifampicin-resistant or multidrug-resistant (MDR) tuberculosis in Vietnam. Contacts of any age with a positive tuberculin skin test or immunologic impairment were eligible. The primary end point was bacteriologically confirmed tuberculosis within 30 months. Secondary end points included grade 3 or 4 adverse events, death from any cause, and acquired drug resistance. RESULTS: Of 3948 persons screened for eligibility, 61 (1.5%) had coprevalent tuberculosis (defined as active tuberculosis disease diagnosed before randomization) and 2041 underwent randomization. Of these 2041 participants, 1995 (97.7%) completed 30 months of follow-up, had a primary end-point event, or died. Confirmed tuberculosis occurred in 6 participants (0.6%) in the levofloxacin group and 11 (1.1%) in the placebo group (incidence rate ratio, 0.55; 95% confidence interval [CI], 0.19 to 1.62); this difference was not significant. There was little difference in grade 3 or 4 adverse events between the two groups (risk difference, 1.0 percentage point; 95% CI, -0.3 to 2.4). Adverse events of any grade were reported in 306 participants (31.9%) taking levofloxacin and 125 (13.0%) taking placebo (risk difference, 18.9 percentage points; 95% CI, 14.2 to 23.6). No acquired fluoroquinolone resistance was observed. CONCLUSIONS: Although the incidence of tuberculosis was lower in the levofloxacin group than in the placebo group at 30 months, the difference was not significant. (Funded by the National Health and Medical Research Council of Australia; VQUIN MDR Australia New Zealand Clinical Trials Registry number, ACTRN12616000215426.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
万能图书馆的应助被Louislee采纳,获得10
2秒前
3秒前
sjn完成签到,获得积分10
5秒前
6秒前
cccsh完成签到 ,获得积分10
7秒前
8秒前
舒服的荧完成签到,获得积分10
9秒前
9秒前
思源的应助被labor采纳,获得30
10秒前
ldxghh发布了新的文献求助10
12秒前
香蕉觅云的应助被thisXiao6采纳,获得10
16秒前
科研通AI6.3的应助被刻苦灯泡采纳,获得10
18秒前
yy完成签到 ,获得积分10
23秒前
PeizeWu完成签到,获得积分10
24秒前
二氧化碳喲完成签到,获得积分10
25秒前
26秒前
浅荫完成签到,获得积分10
28秒前
thisXiao6发布了新的文献求助10
31秒前
斯文尔珍完成签到,获得积分10
34秒前
小华完成签到 ,获得积分10
36秒前
小二郎的应助被hyxiaoren采纳,获得20
39秒前
44秒前
隐形的冷亦完成签到,获得积分10
48秒前
盒子的应助被thisXiao6采纳,获得30
49秒前
labor发布了新的文献求助30
49秒前
50秒前
51秒前
852的应助被亚历山大采纳,获得10
51秒前
53秒前
57秒前
cxw陈祥薇完成签到 ,获得积分10
58秒前
刻苦灯泡发布了新的文献求助10
58秒前
1分钟前
小鱼儿发布了新的文献求助10
1分钟前
郑嘉辉完成签到 ,获得积分10
1分钟前
稳重又琴发布了新的文献求助60
1分钟前
1分钟前
1分钟前
亚历山大发布了新的文献求助10
1分钟前
2589发布了新的文献求助20
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565479
关于积分的说明 21780029
捐赠科研通 7764837
什么是DOI,文献DOI怎么找? 3431499
关于科研通互助平台的介绍 2555519
邀请新用户注册赠送积分活动 2476579